[en] Statins are essential drugs for the prevention of coronary artery disease. There is now evidence that they can also prevent ischemic stroke. The protective effect is related to the reduction in total and LDL cholesterol levels and the clinical benefit is especially high in secondary prevention patients with previous stroke and/or transient ischemic accident. The favourable role of statins is less well documented during an acute stroke than during an acute coronary syndrome, and certainly deserves further studies. Besides their specific cholesterol-lowering effect, statins exert various pleiotropic effects, which probably contribute to vascular protection. Furthermore, statins are able to reduce the formation of beta-amyloid peptide, which plays a key-role in the pathogenesis of Alzheimer disease. However, currently available results are heterogeneous and could not firmly support a protective effect of statins in dementia in general, neither in Alzheimer disease more specifically, nor in the reduction of cognitive function in the elderly. Several ongoing trials should confirm or not confirm this new potential indication of statins in a near future.
Disciplines :
Neurologie
Auteur, co-auteur :
Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale
Radermecker, Régis ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques
Sadzot, Bernard ; Centre Hospitalier Universitaire de Liège - CHU > Neurologie Sart Tilman
Langue du document :
Français
Titre :
Des statines pour le cerveau. Le point en 2008.
Titre traduit :
[en] Statin for the brain: update in 2008
Date de publication/diffusion :
2008
Titre du périodique :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Maison d'édition :
Université de Liège. Revue Médicale de Liège, Liège, Belgique
Scheen AJ, Radermecker RP, De Flines J, et al. - Actualités thérapeutiques en lipidologie. Rev Med Liège, 2007, 62, 324-328.
Cholesterol Treatment Trialists' (CTT) Collaborators. - Efficacy and safety of cholesterol-lowering treatment : prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet, 2005, 366, 1267-1278.
Cholesterol Treatment Trialists' (CTT) Collaborators. - Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet, 2008, 371, 117-125.
Buhaescu I, Izzedine H. - Mevalonate pathway: a review of clinical and therapeutical implications. Clin Biochem, 2007, 40, 575-584.
Reid PC, Urano Y, Kodama T, Hamakubo T. - Alzheimer's disease: cholesterol, membrane rafts, isoprenoids and statins. J Cell Mol Med, 2007, 11, 383-392.
Miida T, Takahashi A, Ikeuchi T. - Prevention of stroke and dementia by statin therapy : experimental and clinical evidence of their pleiotropic effects. Pharmacol Ther, 2007, 113, 378-393.
Cimino M, Gelosa P, Gianella A, et al. - Statins : multiple mechanisms of action in the ischemic brain. Neuroscientist, 2007, 13, 208-213.
Rajanikant GK, Zemke D, Kassab M, Majid A. - The therapeutic potential of statins in neurological disorders. Curr Med Chem, 2007, 14, 103-112.
Canevari L, Clark JB. - Alzheimer's disease and cholesterol: the fat connection. Neurochem Res, 2007, 32, 739-750.
Li G, Larson EB, Sonnen JA, et al. - Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology, 2007, 69, 878-885.
Höglund K, Blennow K. - Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease. CNS Drugs, 2007, 21, 449-462.
Zipp F, Waiczies S, Aktas O, et al. - Impact of HMG-CoA reductase inhibition on brain pathology. Trends Pharmacol Sci, 2007, 28, 342-349.
Reiss AB, Wirkowski E. - Role of HMG-CoA reductase inhibitors in neurological disorders : progress to date. Drugs, 2007, 67, 2111-2120.
Sadzol B, Hans G, Bottin P, Moonen G. - Des statines pour le cerveau ? Rev Med Liège, 2003, 58, 621-627.
Scheen AJ, Sadzot B. - Quelles indications pour les statines hormis le traitement de l'hypercholestérolémie ? Rev Med Suisse, 2005, 1, 1954-1959.
Prospective Studies Collaboration. - Blood cholesterol and vascular mortality by age, sex, and blood pressure: meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths. Lancet, 2007, 370, 1829-1839.
Paciaroni M, Hennerici M, Agnelli G, et al. - Statins and stroke prevention. Cerebrovasc Dis, 2007, 24, 170-182.
Blanco M, Nombela F, Castellanos M, et al. - Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology, 2007, 69, 904-910.
O'Regan C, Wu P, Arora P. et al. - Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients. Am J Med, 2008, 121, 24-33.
Henyan NN, Riche DM, East HE, Gann PN. - Impact of statins on risk of stroke : a meta-analysis. Ann Pharmacother, 2007, 41, 2055-2057.
Goldstein LB. - Low LDL cholesterol, statins, and brain hemorrhage. Should we worry ? Neurology, 2007, 68, 719-720.
Trimble JL, Kockler DR. - Statin treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Ann Pharmacother, 2007, 41, 2019-2023.
Amarenco P, Bogousslavsky J, Callahan A 3rd, et al, the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. - High-dose atorvastatin after stroke or transient ischemic attack. New Engl J Med, 2006, 355, 549-559.
Amarenco P. - Atorvastatin in prevention of stroke and transient ischaemic attack. Expert Opin Pharmacother, 2007, 8, 2789-2797.
Scheen AJ. - L'étude IDEAL comparant simvastatine 20-40 mg versus atorvastatine 80 mg en prévention après un infarctus du myocarde : entre deux idées de l'idéal. Rev Med Liège, 2006, 61, 53-59.
Afilalo J, Duque G, Steele R, et al. - Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis. J Am Coll Cardiol, 2008, 51, 37-45.
Crouse JR, Raichlen JS, Riley WA, et al for the METEOR Study Group. - Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis. The METEOR trial. JAMA, 2007, 297, 1344-1353.
Amarenco P, Labreuche J, Lavallee P, et al. - Statins in stroke prevention and carotid atherosclerosis : systematic review and up-to-date meta-analysis. Stroke, 2004, 35, 2902-2909.
Montaner J, Chacon P, Krupinski J, et al. - Simvastatin in the acute phase of ischemic stroke : a safety and efficacy pilot trial. Eur J Neurol, 2008, 15, 82-90.
Sparks DL, Sabbagh M, Connor D, et al. - Statin therapy in Alzheimer's disease. Acta Neurol Scand Suppl, 2006, 185, 78-86.
Zhou B, Teramukai S, Fukushima M. - Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis. Dement Geriatr Cogn Disord, 2007, 23, 194-201.
Whitfield JF. - Can statins put the brakes on Alzheimer's disease'? Expert Opin Investig Drugs, 2006, 15, 1479-1485.
Hoyer S, Riederer P. - Alzheimer disease - no target for statin treatment. A mini review. Neurochem Res, 2007, 32, 695-706.
Shepherd J, Blauw GJ, Murphy MB, et al. - Pravastatin in elderly individuals at risk of vascular disease (PROSPER) : a randomised controlled trial. Lancet, 2002, 360, 1623-1630.
Heart Protection Study Collaborative Group. - Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20,536 people with cerebrovascular disease or high-risk conditions. Lancet, 2004, 363, 757-767.
Scheen A.J. - Comment j'explore... Les secrets d'une méta-analyse. Rev Med Liège, 2003, 58, 41-46.
